Literature DB >> 29165287

Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.

Harry Quon1, Xuan Hui2, Zhi Cheng2, Scott Robertson2, Luke Peng2, Michael Bowers2, Joseph Moore2, Amanda Choflet2, Alex Thompson2, Mariah Muse2, Ana Kiess2, Brandi Page2, Carole Fakhry3, Christine Gourin3, Jolyne O'Hare4, Peter Graham4, Michal Szczesniak5, Julia Maclean5, Ian Cook5, Todd McNutt2.   

Abstract

PURPOSE: To test the hypothesis that quantifying swallow function with multiple patient-reported outcome (PRO) instruments is an important strategy to yield insights in the development of personalized deintensified therapies seeking to reduce the risk of head and neck cancer (HNC) treatment-related dysphagia (HNCTD). METHODS AND MATERIALS: Irradiated HNC subjects seen in follow-up care (April 2015 to December 2015) who prospectively completed the Sydney Swallow Questionnaire (SSQ) and the MD Anderson Dysphagia Inventory (MDADI) concurrently on the web interface to our Oncospace database were evaluated. A correlation matrix quantified the relationship between the SSQ and MDADI. Machine-learning unsupervised cluster analysis using the elbow criterion and CLUSPLOT analysis to establish its validity was performed.
RESULTS: We identified 89 subjects. The MDADI and SSQ scores were moderately but significantly correlated (correlation coefficient -0.69). K-means cluster analysis demonstrated that 3 unique statistical cohorts (elbow criterion) could be identified with CLUSPLOT analysis, confirming that 100% of variances were accounted for. Correlation coefficients between the individual items in the SSQ and the MDADI demonstrated weak to moderate negative correlation, except for SSQ17 (quality of life question).
CONCLUSIONS: Pilot analysis demonstrates that the MDADI and SSQ are complementary. Three unique clusters of patients can be defined, suggesting that a unique dysphagia signature for HNCTD may be definable. Longitudinal studies relying on only a single PRO, such as MDADI, may be inadequate for classifying HNCTD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29165287     DOI: 10.1016/j.ijrobp.2017.08.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  Revisiting the dose constraints for head and neck OARs in the current era of IMRT.

Authors:  N Patrik Brodin; Wolfgang A Tomé
Journal:  Oral Oncol       Date:  2018-09-08       Impact factor: 5.337

2.  A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma.

Authors:  Lu Xing; Mingzhu Guo; Xiaoqi Zhang; Xiaoqian Zhang; Feng Liu
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-17       Impact factor: 4.553

3.  Validation and Reliability of the French Version of the Sydney Swallow Questionnaire.

Authors:  Nicolas Audag; Christophe Goubau; Etienne Danse; Laure Vandervelde; Giuseppe Liistro; Michel Toussaint; Gregory Reychler
Journal:  Dysphagia       Date:  2019-02-01       Impact factor: 3.438

Review 4.  Big Data in Head and Neck Cancer.

Authors:  Carlo Resteghini; Annalisa Trama; Elio Borgonovi; Hykel Hosni; Giovanni Corrao; Ester Orlandi; Giuseppina Calareso; Loris De Cecco; Cesare Piazza; Luca Mainardi; Lisa Licitra
Journal:  Curr Treat Options Oncol       Date:  2018-10-25

5.  [The German Sydney Swallow Questionnaire : Reliability and validity in patients with oropharyngeal dysphagia].

Authors:  J E Bohlender; S Frick; U Colotto; S Hotzenköcherle; M Brockmann-Bauser
Journal:  HNO       Date:  2021-02-19       Impact factor: 1.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.